Persistently Negative (1,3) β-D-Glucan in Adults with Candidemia is associated with a better prognosis.

Clinical Relevance and Prognostic Value of Persistently Negative (1,3) β-D-Glucan in Adults with Candidemia: a 5-year experience in a tertiary hospital.

  • Agnelli C. et al.
  • Rédigé par : Dr Jean-Pierre Bru
(1, 3)-β-D-glucan (BDG) is a major cell-wall constituent of most pathogenic fungi. It is widely used as a surrogate marker to support the early diagnosis of several invasive fungal infections (IFI), including candidemia. Despite high negative predictive value, some false negative of BDG are reported. The clinical relevance and the potential prognostic role of persistently negative BDG in adults...
Ce contenu est à destination des professionnels de santé. Merci de vous identifier.
This content is intended for healthcare professionals. Thank you for identifying yourself.

Déjà inscrit / Already registered ?

Créer un compte / Create an account

Créer un compte ne prend que quelques minutes et vous permettra d'accèder à l'ensemble des contenus du site.
Creating an account takes only instant and will allow you to access all the content of the website.